The Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI) has received special funding from the NCI Director for the Confluence Project, a large multi-racial genome-wide association study (GWAS) of breast cancer to investigate genetic susceptibility, and genetic determinants of response to treatment and second cancers.
To be eligible to participate in the Confluence Project, studies of in situ or invasive breast cancer (females or males) must have:
- Genome-wide genotyping data or germline DNA for genotyping, i.e.:
- existing genome-wide genotyping data, or
- germline DNA available for new genotyping, or
- blood/buccal samples for germline DNA isolation and genotyping.
- Basic phenotype data (e.g. age at diagnosis, gender, family history of breast cancer)
- Appropriate ethics approval for genetic studies and data sharing
See the Confluence Project Summary
for more information, including principles and governance, and approximate timeline.
Please complete the study inventory if you are interested in participating in the Confluence project. This inventory is for planning purposes only and implies no commitment to participate.
PLEASE NOTE: Data must be entered into the form at one time. Your study information will not be saved if you exit before submitting. If you have any questions, please contact the Project Manager, Ann Truelove, at ConfluenceProject@nih.gov.
Please refer to this document for information that will be requested before completing this form.